Revenue (Quarterly) Chart

View Revenue (Quarterly) for WCIG.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 2009. Start Trial.
Date Value
June 30, 2026 0.00
March 31, 2026 0.00
September 30, 2025 0.00
June 30, 2025 0.00
March 31, 2025 0.00
September 30, 2024 0.00
December 31, 2023
September 30, 2023
June 30, 2023
March 31, 2023
December 31, 2022 0.00
September 30, 2022 0.00
June 30, 2022 0.00
March 31, 2022 0.00
December 31, 2021 0.00
September 30, 2021 0.0119M
June 30, 2021 0.00
March 31, 2021 0.00
December 31, 2020
September 30, 2020 0.00
June 30, 2020 0.00
March 31, 2020 0.00
December 31, 2019 0.00
September 30, 2019 0.00
June 30, 2019 0.00
Date Value
March 31, 2019 0.00
December 31, 2018 0.00
September 30, 2018 0.00
June 30, 2018 0.00
March 31, 2018 0.00
December 31, 2017 0.00
September 30, 2017 0.00
June 30, 2017 0.0078M
March 31, 2017 0.0156M
December 31, 2016 0.0094M
September 30, 2016 0.02M
June 30, 2016 0.0098M
March 31, 2016 0.0186M
December 31, 2015 0.0127M
September 30, 2015 0.0142M
June 30, 2015 0.0189M
March 31, 2015 0.0149M
December 31, 2014 0.015M
September 30, 2014 0.0152M
June 30, 2014 0.0371M
March 31, 2014 0.00
December 31, 2013 0.00
September 30, 2013 0.00
June 30, 2013 0.00
March 31, 2013 0.00

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Arcis Resources Corp. --
Altria Group, Inc. 5.356B
Philip Morris International, Inc. 11.16B
Universal Corp. 523.78M
BioRegenx, Inc. 0.4262M

Revenue (Quarterly) Related Metrics